Kopran Limited

NSE KOPRAN.NS

Kopran Limited Revenue Per Share for the year ending March 31, 2024: USD 1.52

Kopran Limited Revenue Per Share is USD 1.52 for the year ending March 31, 2024, a 9.11% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

Kopran Limited Revenue Per Share for the year ending March 31, 2023 was USD 1.39, a -1.36% change year over year.
Kopran Limited Revenue Per Share for the year ending March 31, 2022 was USD 1.41, a -7.28% change year over year.
Kopran Limited Revenue Per Share for the year ending March 31, 2021 was USD 1.52, a 41.42% change year over year.
Kopran Limited Revenue Per Share for the year ending March 31, 2020 was USD 1.08, a -7.35% change year over year.

Key data

Date	Revenue Per Share	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)

NSE: KOPRAN.NS

Kopran Limited

CEO	Mr. Surendra Shrikrishna Somani B.Com.
IPO Date	July 1, 2002
Location	India
Headquarters	Parijat House
Employees	842
Sector	Health Care
Industries Pharmaceuticals

Description

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai, India.

Key trends

Past 5 years